Avantor, Inc. (NYSE:AVTR) Shares Purchased by DAVENPORT & Co LLC

DAVENPORT & Co LLC boosted its stake in Avantor, Inc. (NYSE:AVTRFree Report) by 17.6% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,283,767 shares of the company’s stock after acquiring an additional 342,452 shares during the period. DAVENPORT & Co LLC owned 0.34% of Avantor worth $52,430,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in the stock. Oak Thistle LLC acquired a new position in Avantor in the 4th quarter valued at about $339,000. Veracity Capital LLC acquired a new position in Avantor in the 4th quarter valued at about $816,000. Norris Perne & French LLP MI increased its position in Avantor by 0.4% in the 4th quarter. Norris Perne & French LLP MI now owns 467,070 shares of the company’s stock valued at $10,663,000 after acquiring an additional 2,084 shares during the period. Fifth Third Bancorp increased its position in Avantor by 125.3% during the 4th quarter. Fifth Third Bancorp now owns 1,248 shares of the company’s stock worth $28,000 after purchasing an additional 694 shares during the period. Finally, Procyon Advisors LLC acquired a new position in Avantor during the 4th quarter worth approximately $228,000. Institutional investors and hedge funds own 95.08% of the company’s stock.

Avantor Trading Down 1.0 %

Shares of AVTR stock traded down $0.26 during mid-day trading on Tuesday, hitting $24.98. 4,166,682 shares of the company’s stock were exchanged, compared to its average volume of 6,060,422. Avantor, Inc. has a fifty-two week low of $16.63 and a fifty-two week high of $26.16. The stock has a 50-day simple moving average of $24.36 and a two-hundred day simple moving average of $22.10. The company has a quick ratio of 1.05, a current ratio of 1.61 and a debt-to-equity ratio of 1.00. The stock has a market cap of $16.94 billion, a price-to-earnings ratio of 51.98, a PEG ratio of 1.61 and a beta of 1.37.

Avantor (NYSE:AVTRGet Free Report) last posted its quarterly earnings data on Wednesday, February 14th. The company reported $0.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.22 by $0.03. Avantor had a return on equity of 14.11% and a net margin of 4.61%. The business had revenue of $1.72 billion for the quarter, compared to analysts’ expectations of $1.70 billion. During the same quarter last year, the firm earned $0.32 earnings per share. The business’s revenue was down 4.0% on a year-over-year basis. Equities analysts expect that Avantor, Inc. will post 1.01 EPS for the current fiscal year.

Insider Activity at Avantor

In related news, EVP James Bramwell sold 6,203 shares of Avantor stock in a transaction on Tuesday, February 27th. The stock was sold at an average price of $24.49, for a total value of $151,911.47. Following the transaction, the executive vice president now owns 101,143 shares in the company, valued at $2,476,992.07. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.50% of the stock is owned by insiders.

Analyst Ratings Changes

Several equities analysts have issued reports on AVTR shares. Raymond James boosted their target price on Avantor from $22.50 to $26.00 and gave the stock an “outperform” rating in a research report on Friday, January 26th. Deutsche Bank Aktiengesellschaft boosted their target price on Avantor from $20.00 to $22.00 and gave the stock a “hold” rating in a research report on Tuesday, December 12th. JPMorgan Chase & Co. boosted their target price on Avantor from $26.00 to $29.00 and gave the stock an “overweight” rating in a research report on Thursday, February 15th. Royal Bank of Canada upped their price target on Avantor from $28.00 to $29.00 and gave the stock an “outperform” rating in a report on Thursday, February 15th. Finally, TD Cowen raised Avantor from a “market perform” rating to an “outperform” rating and raised their price objective for the company from $21.00 to $28.00 in a research note on Monday, December 11th. Four investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $26.14.

View Our Latest Stock Analysis on AVTR

About Avantor

(Free Report)

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

Recommended Stories

Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTRFree Report).

Institutional Ownership by Quarter for Avantor (NYSE:AVTR)

Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.